Abstract
To identify the underlying mechanism of amenorrhea in juvenile systemic lupus erythematosus (JSLE) patients, thirty-five (11.7%) JSLE patients with current or previous amenorrhea were consecutively selected among the 298 post-menarche patients followed in 12 Brazilian pediatric rheumatology centers. Pituitary gonadotrophins [follicle-stimulating hormone (FSH) and luteinizing hormone (LH)] and estradiol were evaluated in 32/35 patients, and prolactin and total testosterone in 29/35 patients. Patient’s medical records were carefully reviewed according to demographic, clinical and therapeutic findings. The mean duration of amenorrhea was 7.2 ± 3.6 months. Low FSH or LH was observed in 7/32 (22%) JSLE patients and normal FSH or LH in 25 (78%). Remarkably, low levels of FSH or LH were associated with higher frequency of current amenorrhea (57% vs. 0%, P = 0.001), higher median disease activity (SLEDAI) and damage (SLICC/ACR-DI) (18 vs. 4, P = 0.011; 2 vs. 0, P = 0.037, respectively) and higher median current dose of prednisone (60 vs. 10 mg/day, P = 0.0001) compared to normal FSH or LH JSLE patients. None of them had decreased ovarian reserve and premature ovarian failure. Six of 29 (21%) patients had high levels of prolactin, and none had current amenorrhea. No correlations were observed between levels of prolactin and SLEDAI, and levels of prolactin and SLICC/ACR-DI scores (Spearman′s coefficient). We have identified that amenorrhea in JSLE is associated with high dose of corticosteroids indicated for active disease due to hypothalamic-pituitary-ovary axis suppression.
Similar content being viewed by others
References
Gurtcheff S, Hatasaka H (2006) Fertility and autoimmune disease. In: Lockshin M, Branch W (eds) Handbook of systemic autoimmune disease. Reproductive and hormonal aspects of systemic autoimmune disease, vol 4. Elsevier, Amsterdam, pp 29–42
Schaller J (1982) Lupus in childhood. Clin Rheum Dis 8:219–228
Silva CA, Leal MM, Leone C et al (2002) Gonadal function in adolescents and young female with systemic lupus erythematosus. Lupus 11:419–425. doi:10.1191/0961203302lu219oa
Silva CA, Hilário MO, Febrônio MV et al (2007) Risk factors for amenorrhea in juvenile systemic lupus erythematosus (JSLE): a Brazilian multicentre cohort study. Lupus 16:531–536. doi:10.1177/0961203307079300
Medeiros PB, Mv Febronio, Bonfa E, Borba EF, Takiuti AD, Silva CA (2009) Menstrual and hormonal alteration in juvenile systemic lupus erythematosus. Lupus 18:38–43. doi:10.1177/0961203308094652
Silva CA, Brunner HI (2007) Gonadal functioning and preservation of reproductive fitness with juvenile systemic lupus erythematosus. Lupus 16:593–599. doi:10.1177/0961203307077538
Metcalf MG, Skidmore D, Lowry GF, Mackenzie JA (1983) Incidence of ovulation in the years after the menarche. J Endocrinol 97:213–219. doi:10.1677/joe.0.0970213
Shabanova SS, Ananieva LP, Alekberova ZS, Guzov II (2008) Ovarian function and disease activity in patients with systemic lupus erythematosus. Clin Exp Rheumatol 26:436–441
Ronchezel MV, Len CA, Spinola e Castro A et al (2001) Thyroid function and serum prolactin levels in patients with juvenile systemic lupus erythematosus. J Pediatr Endocrinol Metab 14:165–169
Boumpas DT, Austin HA, Vaughan EM, Yarboro CH, Klippel JH, Balow JE (1993) Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy. Ann Intern Med 119:366–369
Wang CL, Wang F, Bosco JJ (1995) Ovarian failure in oral cyclophosphamide treatment for systemic lupus erythematosus. Lupus 4:11–14. doi:10.1177/096120339500400103
Mok CC, Lau CS, Wong RW (1998) Risk factors for ovarian failure in patients with systemic lupus erythematosus receiving cyclophosphamide therapy. Arthritis Rheum 41:831–837. doi:10.1002/1529-0131(199806)41:6<1090:AID-ART16>3.0.CO;2-6
Fatnoon NN, Azarisman SM, Zainal D (2008) Prevalence and risk factors for menstrual disorders among systemic lupus erythematosus patients. Singapore Med J 49:413–418
Gonzalez-Crespo MR, Gomez-Reino JJ, Merino R et al (1995) Menstrual disorders in girls with systemic lupus erythematosus treated with cyclophosphamide. Br J Rheumatol 34:737–741. doi:10.1093/rheumatology/34.8.737
Brunner HI, Silverman ED, To T, Bombardier C, Feldman BM (2002) Risk factors for damage in childhood-onset systemic lupus erythematosus: cumulative disease activity and medication use predict disease damage. Arthritis Rheum 46:436–444. doi:10.1002/art.10072
Brunner HI, Bishnoi A, Barron AC et al (2006) Disease outcomes and ovarian function of childhood-onset systemic lupus erythematosus. Lupus 15:198–206. doi:10.1191/0961203306lu2291oa
Ravelli A, Duarte-Salazar C, Buratti S et al (2003) Assessment of damage in juvenile-onset systemic lupus erythematosus: a multicenter cohort study. Arthritis Rheum 49:501–507. doi:10.1002/art.11205
Saketos M, Sharma N, Santoro NF (1993) Suppression of the hypothalamic-pituitary-ovarian axis in normal women by glucocorticoids. Biol Reprod 49:1270–1276. doi:10.1095/biolreprod49.6.1270
Pasoto SG, Mendonça BB, Bonfá E (2002) Menstrual disturbances in patients with systemic lupus erythematosus without alkylating therapy: clinical, hormonal and therapeutic associations. Lupus 11:175–180. doi:10.1191/0961203302lu163oa
Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725. doi:10.1002/art.1780400928
Marshall JC, Tanner JM (1970) Variations in patterns of pubertal changes in boys and girls. Arch Dis Child 45:13–23. doi:10.1136/adc.45.239.13
Zerwes EP, Ferreira C, Zerwes FP, Horta BL (1995) Regularidade do ciclo menstrual pós menarca. Rev Bras Ginecol Obstet 17:76–78
Huong DL, Amoura Z, Duhaut P et al (2002) Risk of ovarian failure and fertility after intravenous cyclophosphamide. A study in 84 patients. J Rheumatol 29:2571–2576
Niaudet P (2000) Treatment of lupus nephritis in children. Pediatr Nephrol 14:158–166. doi:10.1007/s004670050034
Brunner HI, Silverman ED, To T, Bombardier C, Feldman BM (1999) Sensitivity of the systemic lupus erytematosus disease activity index, British Isles lupus assessment group index, and systemic lupus activity measure in the evaluation of clinical change in childhood-onset systemic lupus erytematosus. Arthritis Rheum 42:1354–1360. doi:10.1002/1529-0131(199907)42:7<1354:AID-ANR8>3.0.CO;2-4
Gladman D, Urowitz M, Fortin P et al (1996) The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 39:363–369. doi:10.1002/art.1780390303
Soares PM, Borba EF, Bonfa E, Hallak J, Corrêa AL, Silva CA (2007) Gonad evaluation in male systemic lupus erythematosus. Arthritis Rheum 56:2352–2361. doi:10.1002/art.22660
Suehiro RM, Borba EF, Bonfa E et al (2008) Testicular Sertoli cell function in male systemic lupus erythematosus. Rheumatology 47:1692–1697. doi:10.1093/rheumatology/ken338
Orbach H, Shoenfeld Y (2007) Hyperprolactinemia and autoimmune diseases. Autoimmun Rev 6:537–542. doi:10.1016/j.autrev.2006.10.005
Speroff L, Fritz MA (2005) Amenorrhea. In: Speroff L, Fritz MA (eds) Clinical gynecology endocrinology and infertility, 7th edn. Lippincott Williams and Williams, Philadelphia, pp 401–463
Pasoto SG, Viana VS, Mendonca BB, Yoshinari NH, Bonfa E (1999) Anti-corpus luteum antibody: a novel serological marker for ovarian dysfunction in systemic lupus erythematosus? J Rheumatol 26:1087–1093
Axelrod L (1976) Glucocorticoid therapy. Medicine 55:39–65. doi:10.1097/00005792-197601000-00003
Nelson AM, Conn DL (1980) Series on pharmacology in practice. Glucocorticoids in rheumatic disease. Mayo Clin Proc 55:758–769
Gallant C, Kenny P (1986) Oral glucocorticoids and their complications. A review. J Am Acad Dermatol 14:161–177. doi:10.1016/S0190-9622(86)70018-2
Acknowledgments
This study was supported by Conselho Nacional de Desenvolvimento Científico e Tecnológico–CNPQ (grants 300248/2008-3 to CAAS, 305468/2006-5 to EB, and 301487/2007-3 to MOH) and Federico Foundation Grant to EB. The authors thank the Brazilian Society of Rheumatology and the Brazilian Society of Paediatric, and the following pediatric rheumatologists for evaluating their patients: Rozana G. Almeida, Adriana R. Fonseca, Edson M. Yamashita, Marcos V. Ronchezel, Luciene L. Campos, Simone Appenzeller, Ana B. Santos, Ana C. Medeiros, Luciana M. Carvalho and Silvana P. Cardin. Our gratitude to Ulysses Doria Filho for performing the statistical analysis. This paper was primarily developed in Paediatric Department of Faculdade de Medicina da Universidade de São Paulo, Brazil, in collaboration with a Graduate Student of the Medical Faculty of the Rijks Universiteit Groningen, Netherlands.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Silva, C.A., Deen, M.E.J., Febrônio, M.V. et al. Hormone profile in juvenile systemic lupus erythematosus with previous or current amenorrhea. Rheumatol Int 31, 1037–1043 (2011). https://doi.org/10.1007/s00296-010-1389-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-010-1389-2